[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6010 followers
Created: 2025-07-17 15:01:15 UTC

Vimta Labs Q1 FY2025 Results: Revenue Hits ₹3,482M, Net Profit at ₹122.81M 📊 | MCap XXXXXXXX Cr

- Total income for Q1 FY2025: ₹3,482.22M (₹3,439.82M from operations, ₹42.40M other income).
- Total expenses: ₹2,592.22M (employee benefits: ₹970.18M, depreciation & amortization: ₹352.89M).
- Profit before tax (continuing ops): ₹890.00M; net profit after discontinued ops: ₹122.81M.
- Loss from discontinued ops (sale of Diagnostic/Pathological business to Thyrocare): ₹16.24M.
- Basic EPS: ₹0.63 (continuing ops), ₹(0.07) (discontinued ops).
- Bonus shares issued (1:1 ratio), transferring ₹44.51M from securities premium to share capital.
- ESOP grants adjusted (42,589 options issued to employees).

Complete Source:

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Preview 👇 (First X out of X pages)

![](https://pbs.twimg.com/media/GwEWcn6XIAAQhLh.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945861361868980370/c:line.svg)

**Related Topics**
[tax bracket](/topic/tax-bracket)
[mcap](/topic/mcap)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1945861361868980370)